Literature DB >> 28087183

Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations.

Shouhei Noshiro1, Takeshi Mikami2, Yuko Kataoka-Sasaki3, Masanori Sasaki4, Hirofumi Ohnishi5, Shunya Ohtaki1, Masahiko Wanibuchi1, Nobuhiro Mikuni6, Jeffery D Kocsis7, Osamu Honmou4.   

Abstract

Cerebral cavernous malformations (CCMs) are congenital abnormal clusters of capillaries that are prone to leaking and thought to result from a disorder of endothelial cells. The underlying pathology of CCM is not fully understood. We analyzed the expression of tissue factor (TF) and interleukin-6 (IL-6) in CCMs to determine the association of TF and IL-6 with clinical and pathological findings. Thirteen cases of operative specimens of sporadic CCMs were included in this study. The expression of messenger RNA of TF and IL-6 was assayed and the association with clinical factors was investigated. Then, the distribution of TF and IL-6 was examined with immunofluorescence. The mRNA expression of TF of CCMs was significantly higher than that of the control (p=0.017), and was correlated with the number of hemorrhage appearances (p=0.190, ρ=0.62). The mRNA expression level of IL-6 was significantly correlated with the mRNA expression level of TF (p=0.034, ρ=0.58). Examination of immunostained sections indicated that TF+ cells were also positive for IL-6, and distributed around normal endothelial cells. Moreover, the TF+/IL-6+ cells expressed CD31 and VEGFR2. The expressions of IL-6 and TF were correlated, and both were present in the same immature endothelial cells. TF is elevated in CCM and might mediate progressive events. These factors may play a prognostic role in CCM.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral cavernous malformations; Endothelial cell; Tissue factor

Mesh:

Substances:

Year:  2017        PMID: 28087183     DOI: 10.1016/j.jocn.2016.12.023

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.

Authors:  Romuald Girard; Hussein A Zeineddine; Maged D Fam; Anoop Mayampurath; Ying Cao; Changbin Shi; Robert Shenkar; Sean P Polster; Michael Jesselson; Ryan Duggan; Abdul-Ghani Mikati; Gregory Christoforidis; Jorge Andrade; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Transl Stroke Res       Date:  2017-08-17       Impact factor: 6.829

3.  CCM2-deficient endothelial cells undergo a ROCK-dependent reprogramming into senescence-associated secretory phenotype.

Authors:  Corinne Albiges-Rizo; Hans Van Oosterwyck; Eva Faurobert; Daphné Raphaëlle Vannier; Apeksha Shapeti; Florent Chuffart; Emmanuelle Planus; Sandra Manet; Paul Rivier; Olivier Destaing
Journal:  Angiogenesis       Date:  2021-08-03       Impact factor: 9.596

4.  A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).

Authors:  Romuald Girard; Yan Li; Agnieszka Stadnik; Robert Shenkar; Nicholas Hobson; Sharbel Romanos; Abhinav Srinath; Thomas Moore; Rhonda Lightle; Abdallah Shkoukani; Amy Akers; Timothy Carroll; Gregory A Christoforidis; James I Koenig; Cornelia Lee; Kristina Piedad; Steven M Greenberg; Helen Kim; Kelly D Flemming; Yuan Ji; Issam A Awad
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.